Immune Response BioPharma to Seek Emergency Approval of REMUNE in Thailand
4/22/2013 9:30:50 AM
More...
|
Immune Response BioPharma to Seek Orphan Designation of NeuroVax for Pediatric MS
3/13/2013 9:53:18 AM
More...
|
Immune Response BioPharma Files for Orphan Designation of REMUNE for Pediatric HIV/AIDS
12/17/2012 11:48:49 AM
More...
|
Immune Response BioPharma New ZORCELL Psoriasis Vaccine Phase IIb Study Safety & Efficacy
12/11/2012 11:28:48 AM
More...
|
Immune Response BioPharma Files for Orphan Designation of RAVAX for Juvenile RA
10/23/2012 9:42:27 AM
More...
|
Immune Response BioPharma Files for Orphan Designation for NeuroVax for Multiple Sclerosis
10/3/2012 8:35:12 AM
More...
|
Immune Response BioPharma Business Update Sees Blockbuster MS NeuroVax Partnership by Q1 2013
9/28/2012 6:25:27 AM
More...
|
Immune Response BioPharma Release: REMUNE Effectiveness Extends Years After Inoculation REMUNE Patient Has 2 Healthy HIV Free Children
9/25/2012 10:36:22 AM
More...
|
Immune Response BioPharma Sees First Year REMUNE Sales North of $5 Billion Dollars
8/23/2012 10:09:29 AM
More...
|
Immune Response BioPharma Review of Blockbuster RAVAX Phase 2B Study Patients 50% Improvement
7/13/2012 11:09:26 AM
More...
|
|